Park Ha Biological Technology Co. Ltd (PHH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,000 | -16,000 | 72,000 | 212,000 | 220,000 |
| Depreciation Amortization | 1,293,000 | 1,264,000 | 1,437,000 | 1,667,000 | 2,009,000 |
| Income taxes - deferred | -69,000 | -24,000 | N/A | N/A | N/A |
| Other Working Capital | 1,415,000 | -548,000 | -440,000 | 741,000 | 1,561,000 |
| Other Operating Activity | 34,000 | 72,000 | -338,000 | -683,000 | -1,165,000 |
| Operating Cash Flow | $2,663,000 | $748,000 | $731,000 | $1,937,000 | $2,625,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,000 | -26,000 | -20,000 | -25,000 | -39,000 |
| Net Acquisitions | N/A | -2,000 | -7,000 | -27,000 | -2,000 |
| Purchase Of Investment | -2,255,000 | -2,539,000 | -2,518,000 | -2,155,000 | -1,894,000 |
| Sale Of Investment | 869,000 | 1,135,000 | 1,095,000 | 937,000 | 1,000,000 |
| Purchase Sale Intangibles | 195,000 | 5,000 | -97,000 | -50,000 | -51,000 |
| Other Investing Activity | 203,000 | -142,000 | 204,000 | -12,000 | 109,000 |
| Investing Cash Flow | $-1,206,000 | $-1,574,000 | $-1,246,000 | $-1,282,000 | $-826,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -992,000 | 384,000 | 533,000 | -37,000 | -699,000 |
| Debt Issued | 23,684,000 | 23,184,000 | 9,207,000 | 2,712,000 | 20,661,000 |
| Debt Repayment | -24,108,000 | -22,707,000 | -9,516,000 | -3,057,000 | -21,442,000 |
| Common Stock Issued | 6,000 | 1,000 | 115,000 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -6,000 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -140,000 | -140,000 |
| Other Financing Activity | -22,000 | -21,000 | 32,000 | -5,000 | -88,000 |
| Financing Cash Flow | $-1,432,000 | $841,000 | $365,000 | $-527,000 | $-1,708,000 |
| Exchange Rate Effect | 1,000 | 1,000 | N/A | 3,000 | -4,000 |
| Beginning Cash Position | 123,000 | 107,000 | 345,000 | 174,000 | 98,000 |
| End Cash Position | 149,000 | 123,000 | 107,000 | 345,000 | 174,000 |
| Net Cash Flow | $26,000 | $16,000 | $-238,000 | $171,000 | $76,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,663,000 | 748,000 | 731,000 | 1,937,000 | 2,625,000 |
| Capital Expenditure | -23,000 | -26,000 | -20,000 | -25,000 | -39,000 |
| Free Cash Flow | 2,640,000 | 722,000 | 711,000 | 1,912,000 | 2,586,000 |